BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16800959)

  • 1. [Role of B-cell-activating-factor in immune regulation--review].
    Du JF; Wang JX; Xu DG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):631-4. PubMed ID: 16800959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF, APRIL and their receptors: structure, function and signaling.
    Bossen C; Schneider P
    Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell activating factor (BAFF) and BAFF receptors: fakes and facts.
    Ferraccioli G; Gremese E
    Clin Exp Immunol; 2017 Dec; 190(3):291-292. PubMed ID: 28834574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers.
    Wong DP; Roy NK; Zhang K; Anukanth A; Asthana A; Shirkey-Son NJ; Dunmire S; Jones BJ; Lahr WS; Webber BR; Moriarity BS; Caimi P; Parameswaran R
    Nat Commun; 2022 Jan; 13(1):217. PubMed ID: 35017485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
    Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
    Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the BAFF/APRIL system on T cell function.
    Mackay F; Leung H
    Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
    Rickert RC; Jellusova J; Miletic AV
    Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Travelling with the BAFF/BLyS family: are we there yet?
    Mackay F; Cancro MP
    Semin Immunol; 2006 Oct; 18(5):261-2. PubMed ID: 16905331
    [No Abstract]   [Full Text] [Related]  

  • 10. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.
    Frasca D; Riley RL; Blomberg BB
    Exp Gerontol; 2007 Mar; 42(3):192-203. PubMed ID: 17067770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
    Mackay F; Schneider P
    Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
    Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
    Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
    Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
    J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
    Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.
    Uzzan M; Colombel JF; Cerutti A; Treton X; Mehandru S
    Dig Dis Sci; 2016 Dec; 61(12):3407-3424. PubMed ID: 27655102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism.
    Nelke J; Medler J; Weisenberger D; Beilhack A; Wajant H
    MAbs; 2020; 12(1):1807721. PubMed ID: 32840410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
    Xu S; Lam KP
    Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACI and BAFF-R mediate isotype switching in B cells.
    Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
    J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF, APRIL and human B cell disorders.
    Tangye SG; Bryant VL; Cuss AK; Good KL
    Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.